Education and Training
- Resident, Medicine, Duke University, 2004 - 2008
- M.D., Washington University, 2004
Bedoya, AD, Clement, ME, Phelan, M, Steorts, RC, O'Brien, C, and Goldstein, BA. "Minimal Impact of Implemented Early Warning Score and Best Practice Alert for Patient Deterioration." Critical Care Medicine 47, no. 1 (January 2019): 49-55.
Rhee, C, Filbin, MR, Massaro, AF, Bulger, AL, McEachern, D, Tobin, KA, Kitch, BT, Thurlo-Walsh, B, Kadar, A, Koffman, A, Pande, A, Hamad, Y, Warren, DK, Jones, TM, O'Brien, C, Anderson, DJ, Wang, R, Klompas, M, and Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program, . "Compliance With the National SEP-1 Quality Measure and Association With Sepsis Outcomes: A Multicenter Retrospective Cohort Study." Critical Care Medicine 46, no. 10 (October 2018): 1585-1591.
Rhee, C, Brown, SR, Jones, TM, O'Brien, C, Pande, A, Hamad, Y, Bulger, AL, Tobin, KA, Massaro, AF, Anderson, DJ, Warren, DK, Klompas, M, and CDC Prevention Epicenters Program, . "Variability in determining sepsis time zero and bundle compliance rates for the centers for medicare and medicaid services SEP-1 measure." Infection Control and Hospital Epidemiology 39, no. 8 (August 2018): 994-996.
Chudgar, S, McManigle, WC, Graham, AJ, Bae, J, Setji, NP, and O'Brien, CL. "TEACHING ESSENTIAL SKILLS: TRAINING MEDICAL STUDENTS IN QUALITY IMPROVEMENT, PROCEDURES, AND TRANSITIONS OF CARE." June 2013.
"Cost-effectiveness of Ximelagatran for Stroke Prevention—Reply." Jama 293, no. 23 (June 15, 2005): 2860-2860.
O'Brien, CL, and Gage, BF. "Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation." JAMA 293, no. 6 (February 9, 2005): 699-706.
Perret-Guillaume, C, Wahl, D, O'Brien, CL, and Gage, BF. "Cost-effectiveness of ximelagatran for stroke prevention  (multiple letters)." Journal of the American Medical Association 293, no. 23 (2005): 2860-2861.
Brendza, RP, O'Brien, C, Simmons, K, McKeel, DW, Bales, KR, Paul, SM, Olney, JW, Sanes, JR, and Holtzman, DM. "PDAPP; YFP double transgenic mice: A tool to study amyloid-β associated changes in axonal, dendritic, and synaptic structures." Journal of Comparative Neurology 456, no. 4 (2003): 375-383.